Abstract P1-16-03: An open-label, multicenter phase 1b trial of radium-223 + paclitaxel in cancer patients with bone metastases: Safety results from the breast cancer patient subgroup
Keyword(s):
Keyword(s):
2017 ◽
Vol 99
(2)
◽
pp. E269
Keyword(s):
2021 ◽
Vol 9
(E)
◽
pp. 624-628
Keyword(s):
Keyword(s):
Keyword(s):
1997 ◽
Vol 36
(12)
◽
pp. 926-930
◽
Keyword(s):
Keyword(s):